Jintao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jintao Li has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Jianxia Ke
Department of Neurology and Stroke Center, Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, People’s Republic of China
3 shared publications- Zhu Shi
Department of Neurology, 10th Affiliate Hospital (Dongguan People's Hospital), Southern Medical University, Dongguan, China
3 shared publications - Jia Wen
Postgraduate School, Guangdong Medical University, Zhanjiang, Guangdong, People’s Republic of China
2 shared publications Jinrui Li
Department of Neurology and Stroke Center, Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, People’s Republic of China
2 shared publicationsJunting Chen
Postgraduate School, Guangdong Medical University, Zhanjiang, Guangdong, People’s Republic of China
2 shared publicationsBao-Li He
Kunming Medical University,Kunming,Yunnan ,China
1 shared publication
Latest Publications
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 149-159
Brain Frailty on Neuroimaging Beyond Chronological Age Is Associated with Functional Outcome After Endovascular Thrombectomy in Patients with Anterior Large Vessel Occlusion
Background: Current guidelines have not recommended an upper age limit for endovascular thrombectomy (EVT) in patients with large vessel occlusion (LVO) stroke. However, elder age links to an increased risk of poor outcome. This study aimed to investigate the efficacy of EVT in elderly versus non-elderly patients and determine the respective factors of poor outcome. Methods: Three hundred and two consecutive patients with LVO-stroke who underwent EVT were included, and we used sensitivity analysis with restricted cubic spline to define 75 years as the inflexion point. Participants were thus dichotomized into elderly (≥ 75 years) and non-elderly (< 75 years) groups. Brain frailty on neuroimaging was evaluated using the global cortical atrophy (GCA) scale and the Fazekas scale for white matter lesions (WML). The primary outcome was 3-month functional outcome, and the secondary outcomes were EVT efficacy and safety. Results: Elderly patients had significantly higher incidences of hypertension, diabetes mellitus, atrial fibrillation, and more severe GCA and WML. The rate of good outcome in elderly patients was 32%, significantly lower than non-elderly patients (54%, p< 0.001). There was no difference in terms of reperfusion (89% vs 93%, p=0.363) and intracranial hemorrhage (38% vs 41%, p=0.826) between two groups. In elderly patients, high degree of GCA (OR 1.15, 95% CI 1.02– 1.30, p=0.012) and moderate/severe WML (OR 5.88, 95% CI 1.47– 23.50, p=0.015) independently predicted 3-month poor outcomes. Conclusion: GCA and WML play pivotal roles for the functional outcomes in elderly patients undergoing EVT for LVO-stroke, providing valuable and practical information for early prediction of long-term prognosis.
- 1 February 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 149-159
Open AccessBrain Frailty on Neuroimaging Beyond Chronological Age Is Associated with Functional Outcome After Endovascular Thrombectomy in Patients with Anterior Large Vessel Occlusion
Background: Current guidelines have not recommended an upper age limit for endovascular thrombectomy (EVT) in patients with large vessel occlusion (LVO) stroke. However, elder age links to an increased risk of poor outcome. This study aimed to investigate the efficacy of EVT in elderly versus non-elderly patients and determine the respective factors of poor outcome. Methods: Three hundred and two consecutive patients with LVO-stroke who underwent EVT were included, and we used sensitivity analysis with restricted cubic spline to define 75 years as the inflexion point. Participants were thus dichotomized into elderly (≥ 75 years) and non-elderly (< 75 years) groups. Brain frailty on neuroimaging was evaluated using the global cortical atrophy (GCA) scale and the Fazekas scale for white matter lesions (WML). The primary outcome was 3-month functional outcome, and the secondary outcomes were EVT efficacy and safety. Results: Elderly patients had significantly higher incidences of hypertension, diabetes mellitus, atrial fibrillation, and more severe GCA and WML. The rate of good outcome in elderly patients was 32%, significantly lower than non-elderly patients (54%, p< 0.001). There was no difference in terms of reperfusion (89% vs 93%, p=0.363) and intracranial hemorrhage (38% vs 41%, p=0.826) between two groups. In elderly patients, high degree of GCA (OR 1.15, 95% CI 1.02– 1.30, p=0.012) and moderate/severe WML (OR 5.88, 95% CI 1.47– 23.50, p=0.015) independently predicted 3-month poor outcomes. Conclusion: GCA and WML play pivotal roles for the functional outcomes in elderly patients undergoing EVT for LVO-stroke, providing valuable and practical information for early prediction of long-term prognosis.
- Open Access
- 4 June 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (11) , e033981
Heme Oxygenase‐1 Gene (GT)n Polymorphism Linked to Deep White Matter Hyperintensities, Not Periventricular Hyperintensities
Background: Oxidative stress plays a principal role in the pathogenesis of white matter hyperintensities (WMHs). The induction of heme oxygenase‐1 ( HO‐1 ) gene in the brain represents 1 of the pivotal mechanisms to counteract the noxious effects of reactive oxygen species, and the transcriptional modulation of HO‐1 induction depends on the length of a GT‐repeat (GT)n in the promoter region. We investigated whether the HO‐1 gene (GT)n polymorphism is associated with the risk of WMHs. Methods and Results: A total of 849 subjects from the memory clinic were consecutively enrolled, and the HO‐1 (GT)n genotype was determined. WMHs were assessed with the Fazekas scale and further divided into periventricular WMHs and deep WMHs (DWMHs). Allelic HO‐1 (GT)n polymorphisms were classified as short (≤24 (GT)n), median (25≤[GT]nHO‐1 (GT)n variants on WMHs. The number of repetitions of the HO‐1 gene (GT)n ranged from 15 to 39 with a bimodal distribution at lengths 23 and 30. The proportion of S / S genotypes was higher for moderate/severe DWMHs than none/mild DWMHs (22.22% versus 12.44%; P =0.001), but the association for periventricular WMHs was not statistically significant. Logistic regression suggested that the S / S genotype was significantly associated with moderate/severe DWMHs ( S / S versus non‐ S / S : odds ratio, 2.001 [95% CI, 1.323–3.027]; P HO‐1 gene (GT)n S / S genotype and aging synergistically contributed to the progression of DWMHs (relative excess risk attributable to interaction, 6.032 [95% CI, 0.149–11.915]). Conclusions: Short (GT)n variants in the HO‐1 gene may confer susceptibility to rather than protection from DWMHs, but not periventricular WMHs. Registration: URL: https://www.chictr.org.cn ; Unique identifier: ChiCTR2100045869.
- 4 June 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (11) , e033981
Open AccessHeme Oxygenase‐1 Gene (GT)n Polymorphism Linked to Deep White Matter Hyperintensities, Not Periventricular Hyperintensities
Background: Oxidative stress plays a principal role in the pathogenesis of white matter hyperintensities (WMHs). The induction of heme oxygenase‐1 ( HO‐1 ) gene in the brain represents 1 of the pivotal mechanisms to counteract the noxious effects of reactive oxygen species, and the transcriptional modulation of HO‐1 induction depends on the length of a GT‐repeat (GT)n in the promoter region. We investigated whether the HO‐1 gene (GT)n polymorphism is associated with the risk of WMHs. Methods and Results: A total of 849 subjects from the memory clinic were consecutively enrolled, and the HO‐1 (GT)n genotype was determined. WMHs were assessed with the Fazekas scale and further divided into periventricular WMHs and deep WMHs (DWMHs). Allelic HO‐1 (GT)n polymorphisms were classified as short (≤24 (GT)n), median (25≤[GT]nHO‐1 (GT)n variants on WMHs. The number of repetitions of the HO‐1 gene (GT)n ranged from 15 to 39 with a bimodal distribution at lengths 23 and 30. The proportion of S / S genotypes was higher for moderate/severe DWMHs than none/mild DWMHs (22.22% versus 12.44%; P =0.001), but the association for periventricular WMHs was not statistically significant. Logistic regression suggested that the S / S genotype was significantly associated with moderate/severe DWMHs ( S / S versus non‐ S / S : odds ratio, 2.001 [95% CI, 1.323–3.027]; P HO‐1 gene (GT)n S / S genotype and aging synergistically contributed to the progression of DWMHs (relative excess risk attributable to interaction, 6.032 [95% CI, 0.149–11.915]). Conclusions: Short (GT)n variants in the HO‐1 gene may confer susceptibility to rather than protection from DWMHs, but not periventricular WMHs. Registration: URL: https://www.chictr.org.cn ; Unique identifier: ChiCTR2100045869.
- 1 February 2011
- Published by National Space Science Center, Chinese Academy of Sciences
- Vol. 32 (1) , 109-14
[Progress and prospect in research on laboratory tree shrew in China].
We outline the historical research on the laboratory tree shrew in China and discuss its current research trends. Five key aspects of applied research are emphasized in this review, including quality control standards for laboratory tree shrews, the establishment of an inbred colony, commercial preparation of major molecular and cellular research tools, further research on tree shrew models for human diseases, and the establishment of the tree shrew seed institution at state level.
- 1 February 2011
- Published by National Space Science Center, Chinese Academy of Sciences
- Vol. 32 (1) , 109-14
[Progress and prospect in research on laboratory tree shrew in China].
We outline the historical research on the laboratory tree shrew in China and discuss its current research trends. Five key aspects of applied research are emphasized in this review, including quality control standards for laboratory tree shrews, the establishment of an inbred colony, commercial preparation of major molecular and cellular research tools, further research on tree shrew models for human diseases, and the establishment of the tree shrew seed institution at state level.